Slaughter and May advises on agreement between Africa and Johnson & Johnson (JANSSEN) for the purchase of up to 400 million doses of COVID-19 Vaccines

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

USD 2bn (US$2 billion)

What the figure measures

Facility amount

Client

African Vaccine Acquisition Trust (AVAT)Borrower

Counterparties

Johnson & Johnson (Janssen) (Sell-side)
African Export-Import Bank (Afreximbank) (Lenders)